SCHEMBL11295044

SCHEMBL11295044

O=C(NO)c1ccc(N(c2ccc(Cl)c(CO)c2)C2CCNC2=O)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 13/20 0.37
▸ HDAC6 Q9UBN7 9/20 0.37
▸ HDAC1 Q13547 6/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ HDAC9 Q9UKV0 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ PSEN1 P49768 4/20 0.34
▸ PSEN2 P49810 4/20 0.34
▸ APH1B Q8WW43 4/20 0.34
▸ NCSTN Q92542 4/20 0.34
▸ APH1A Q96BI3 4/20 0.34
▸ PSENEN Q9NZ42 4/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ WDR5 P61964 1/20 0.33
▸ HDAC2 Q92769 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11296595 0.88 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC4HDAC7
SCHEMBL11301754 0.84 PSEN1 (0.42) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11303268 0.83 ABL1 (0.37) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11303328 0.83 HDAC8 (0.37) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11298752 0.82 HDAC8 (0.42) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11301603 0.80 HDAC6 (0.38) HDAC8HDAC6HDAC1HDAC4HDAC7
SCHEMBL11304464 0.79 HDAC8 (0.37) HDAC8HDAC6HDAC1PSEN1PSEN2
SCHEMBL11305647 0.79 HDAC6 (0.41) HDAC8HDAC6HDAC1HDAC11
SCHEMBL11299163 0.79 HDAC6 (0.40) HDAC8HDAC6HDAC1HDAC7PSEN1
SCHEMBL11304336 0.79 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
Send feedback